MYCN and neuroblastoma: Of note, neutrophils have been demonstrated to mediate ADCC against neuroblastoma in the presence of anti-GD2 antibody, illuminating a possible link to the enhanced tumor clearance conferred by immunocombination therapy in the Th-MYCN model (Fig. 1b,c)20.